Waters Corporation Receivables Turnover Ratio (WAT), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Waters Corporation  (NYSE: WAT)
 

Waters Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Waters Corporation's ability to collect accounts receivable sequentially worsen to 3.49, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Waters's Accounts Receivable average collection period in the Jul 04 2026 quarter, has increased to 105 days, from 98 days, in the Apr 04 2026 quarter.

If we take a look into Healthcare sector 336 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2235, from overall ranking in the first quarter 2026 at 2680.

What is Receivable Turnover Ratio?
What is Waters Corporation Selling?


What is Receivable Turnover Ratio?





WAT Receivables Turnover Ratio (Jul 04 2026)
II. Quarter
(Apr 04 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 27 2025)
III. Quarter
(Jun 28 2025)
II. Quarter
Y / Y Receivable Change 172.16 % 145.77 % 13.02 % 4580.29 % 5061.72 %
Y / Y Revenue Change 113.27 % 91.48 % 6.83 % 8.05 % 8.86 %
Receivable Turnover Ratio (TTM) 3.49 3.71 4.19 4.25 5.56
WAT's Total Ranking # 2235 # 2680 # 1349 # 0 #
Accounts Receivable average collection period days 104 98 87 86 66
Seq. Receivable Change 13.35 % 111.5 % 10.73 % 2.53 % 2.35 %
Seq. Revenue Change 29.83 % 35.89 % 16.56 % 3.7 % 16.57 %


Receivable Turnover Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 14
Healthcare Sector # 337
Overall Market # 2235

Receivable Turnover Ratio Statistics
High Average Low
0.86 0.64 -0.28
(June 30. 2007)   (Dec 31 2018)






Financial Statements
Waters's Accounts Receivable $ 1,987 Millions Visit WAT's Balance sheet
Waters's Sales TTM $ 4,644 Millions Visit WAT's Income Statement
Sources of WAT's Revenues Visit WAT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
WAT's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
WAT's Growth Rates WAT's Roa WAT's Inventory Turnover Ratio WAT's Dividend Comparisons
WAT's Profitability Ratios WAT's Roi WAT's Asset Turnover Ratio WAT's Dividend Growth
WAT's Valuation Ratios WAT's Roe WAT's Financial Strength Ratios WAT's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jul 04 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jul 04 2026 Receivable at quarter ending Jul 04 2026
Adaptive Biotechnologies Corporation  6.38 $ 308.081  Millions$ 48.254  Millions
Iradimed Corporation  6.38 $ 86.339  Millions$ 13.533  Millions
Edap Tms Sa  6.34 $ 111.051  Millions$ 17.522  Millions
Syndax Pharmaceuticals Inc   6.32 $ 252.004  Millions$ 39.902  Millions
Nuwellis Inc   6.28 $ 9.013  Millions$ 1.435  Millions
Absci Corp  6.24 $ 1.561  Millions$ 0.250  Millions
Maxcyte inc   6.22 $ 31.051  Millions$ 4.994  Millions
Cue Biopharma Inc   6.21 $ 37.654  Millions$ 6.064  Millions
Heartflow Inc   6.20 $ 210.791  Millions$ 33.999  Millions
Omada Health Inc   6.20 $ 308.445  Millions$ 49.770  Millions
Vertex Pharmaceuticals Inc  6.19 $ 12,587.200  Millions$ 2,032.400  Millions
Integra Lifesciences Holdings Corp  6.14 $ 1,647.666  Millions$ 268.153  Millions
Interpace Biosciences Inc   6.12 $ 36.519  Millions$ 5.963  Millions
Treace Medical Concepts Inc   6.12 $ 205.307  Millions$ 33.551  Millions
Femasys Inc   6.08 $ 2.299  Millions$ 0.378  Millions
Capsovision Inc   5.98 $ 12.804  Millions$ 2.140  Millions
Sera Prognostics Inc   5.96 $ 0.070  Millions$ 0.012  Millions
Msa Safety Inc  5.95 $ 1,946.916  Millions$ 327.189  Millions
Bio techne Corp  5.91 $ 1,213.869  Millions$ 205.480  Millions
Pacira Biosciences inc   5.90 $ 746.164  Millions$ 126.498  Millions
Adm Tronics Unlimited Inc   5.89 $ 3.240  Millions$ 0.550  Millions
Mimedx Group Inc   5.87 $ 354.086  Millions$ 60.306  Millions
Conmed Corporation  5.83 $ 1,371.657  Millions$ 235.301  Millions
Infusystem Holdings Inc  5.83 $ 143.335  Millions$ 24.599  Millions
Resmed Inc   5.80 $ 5,628.170  Millions$ 970.458  Millions
Medtronic Plc  5.80 $ 37,542.000  Millions$ 6,476.000  Millions
Gossamer Bio Inc   5.79 $ 53.286  Millions$ 9.207  Millions
Pacific Health Care Organization Inc  5.78 $ 6.442  Millions$ 1.114  Millions
Accuray Incorporated  5.77 $ 400.833  Millions$ 69.455  Millions
Ispecimen inc   5.77 $ 0.466  Millions$ 0.081  Millions

Date modified: 2026-09-04T17:23:32+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.